Synthesis, Screening and Docking Analysis of Novel Benzimidazolium and Benzotriazolium Compounds as Potent Anti Tubercular Agents

Author(s): Padma Vijaya Sangeeta Guruvelli, Pranita Wagmare, Bhaskar C. Harinath, Risy Namratha Jamullamudi, Purna Nagasree Kurre, Murali Krishna Kumar Muthyala*.

Journal Name: Anti-Infective Agents

Volume 17 , Issue 1 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Introduction: Tuberculosis is an infectious bacterial disease that mainly affects the lungs. Globally, there are about 10.5 million new cases and about 1.5 million deaths reported each year as per science daily research news in 2017.

Objective: One of the biggest problems of Tuberculosis is the lack of effective treatments. Bedaquiline (2013) and Delaminid (2014) are the only two agents approved for TB after Rifampicin. This clearly shows the need for new lead molecules to fight against TB.

Methodology: A series of benzimidazolium and benzotriazolium derivatives were synthesized and the structures were confirmed by their IR, 1H NMR,13C NMR and mass spectral data. They were tested for in vitro antitubercular activity by MABA Assay, MTT Assay and axenic culture assay. To determine selective TB activity, they were also tested for antimicrobial activity and cytotoxicity. Docking simulations and drug-inhibitor combination studies were conducted to know the probable mechanism of action.

Results: Among the synthesized compounds B10, B11, B13, B14, B22, B23, B24, B25, B26 and B27 showed excellent anti TB activity with an MIC 3.12-0.8 µg/mL. Among these, compound 1,3- bis(4-chlorobenzyl)-1H-benzo[d]imidazol-3-ium chloride (B11) has shown selective anti TB activity against Mycobacterium tuberculosis H37Rv (0.8µg/mL) in MABA assay. This compound hasn’t shown any antimicrobial (at 100μg/mL) and cytotoxicity (at 10µM). Docking studies and drug-inhibitor combination studies indicated that the compounds might act via enzymes involved in the cell division process.

Conclusion: In conclusion, we synthesized molecules with potent and selective anti TB activity.

Keywords: Benzimidazolium, benzotriazolium, synthesis, molecular docking, anti-mycobacterial, mtFtsZ.

[1]
Kunal, K.; Divya, A.; William, T.; Peter, J. Tonge.; Richard, A.; Slayden.; Iwao Ojima. Discovery of anti-TB agents that target the cell-division protein FtsZ. Future Med. Chem., 2010, 2, 1305-1323.
[2]
Bramhill, D. Bacterial cell division. Annu. Rev. Cell Dev. Biol., 1997, 13, 395-424.
[3]
Lutkenhaus, J.; Addinall, S.G. Bacterial Cell Division and the Z Ring. Annu. Rev. Biochem., 1997, 66, 93-116.
[4]
Romberg, L.; Levin, P.A. Assembly dynamics of the bacterial cell division protein FTSZ: poised at the edge of stability. Annu. Rev. Microbiol., 2003, 57, 125-154.
[5]
Ben Yehuda, S.; Losick, R. Asymmetric cell division in B. subtilis involves a spiral-like intermediate of the cytokinetic protein FtsZ. Cell, 2002, 109, 257-266.
[6]
Goehring, N.W. Beckwith. Diverse paths to midcell: assembly of the bacterial cell division machinery. J. Curr. Biol, 2005, 15, 514-526.
[7]
Leung, A.K.W.; White, E.L.; Ross, L.J.; Reynolds, R.C.; Devito, J.A.; Borhani, D.W. Structure of Mycobacterium tuberculosis FtsZ reveals unexpected, G protein-like conformational switches. J. Mol. Biol., 2004, 342, 953-970.
[8]
Moller-Jensen, J. Loewe. Increasing complexity of the bacterial cytoskeleton. J. Curr. Opin. Cell Biol., 2005, 17, 75-81.
[9]
Thanedar, S.; Margolin, W. FtsZ exhibits rapid movement and oscillation waves in helix-like patterns in Escherichia coli. Curr. Biol., 2004, 14, 1167-1173.
[10]
Respicio, L.; Nair, P.A.; Huang, Q. Characterizing septum inhibition in Mycobacterium tuberculosis for novel drug discovery. Tuberculosis, 2008, 88, 420-429.
[11]
Slayden, R.A.; Knudson, D.L.; Belisle, J.T. Identification of cell cycle regulators in Mycobacterium tuberculosis by inhibition of septum formation and global transcriptional analysis. Microbiology, 2006, 152, 1789-1797.
[12]
Beuria, T.K.; Santra, M.K.; Panda, D. Sanguinarine Blocks Cytokinesis in Bacteria by Inhibiting FtsZ Assembly and Bundling. Biochemistry, 2005, 44, 16584-16593.
[13]
Schaffner-Barbero, C.; Martín-Fontecha, M.; Chacón, P.; Andreu, J.M. Targeting the assembly of bacterial cell division protein FtsZ with small molecules. ACS Chem. Biol., 2012, 7, 269-277.
[14]
Haranahalli, K.; Tong, S.; Ojima, I. Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ. Bioorg. Med. Chem., 2016, 24, 6354-6369.
[15]
Bi, F.; Guo, L.; Wang, Y.; Venter, H.; Semple, S.J.; Liu, F. Design, synthesis and biological activity evaluation of novel 2,6-difluorobenzamide derivatives through FtsZ inhibition. Bioorg. Med. Chem. Lett., 2017, 27, 958-962.
[16]
Reynolds, R.C.; Srivastava, S.; Ross, L.J.; Suling, W.J.; White, E.L. A new 2-carbamoyl pteridine that inhibits mycobacterial FtsZ. Bioorg. Med. Chem. Lett., 2004, 4, 3161-3164.
[17]
Park, B.; Awasthi, D.; Chowdhury, S.R.; Melief, E.H.; Kumar, K.; Knudson, S.E.; Slayden, R.A.; Ojima, I. Design, Synthesis and Evaluation of Novel 2,5,6-Trisubstituted Benzimidazoles Targeting FtsZ as Antitubercular Agents. Bioorg. Med. Chem., 2014, 22, 2602-2612.
[18]
Barot, K.P.; Jain, S.V.; Gupta, N.; Kremer, L.; Singh, S.; Takale, V.B.; Joshi, K.; Ghate, M.D. Design, synthesis and docking studies of some novel (R)-2-(4′-chlorophenyl)-3-(4′-nitrophenyl)-1,2,3,5-tetrahydrobenzo [4,5] imidazo [1,2-c]pyrimidin-4-ol derivatives as antitubercular agents. Eur. J. Med. Chem., 2014, 83, 245-255.
[19]
Shefali Srivastava. Larry, J.; Ross.; William, J.; Suling.; Lucile White, E.; Lisa, K.; Woolhiser.; Anne, J.; Lenaerts, Robert, C.; Reynolds. Novel Pyridopyrazine and Pyrimidothiazine Derivatives as FtsZ Inhibitors. Bioorg. Med. Chem., 2011, 19, 7120-7128.
[20]
White, E.L.; Suling, W.J.; Ross, L.J.; Seitz, L.E.; Reynolds, R.C. 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ. J. Antimicrob. Chemother., 2002, 50, 111-114.
[21]
Yousif, E.; Hameed, A.; Rasheed, R.; Mansoor, H.; Farina, Y.; Salih, A.G.N. Salimon. Synthesis and photostability study of some modified poly (vinyl chloride) containing pendant benzothiazole and benzimidozole ring. J. Int. J. Chem, 2010, 2, 65-80.
[22]
Zhu, Z.Q.; Xiang, S.; Chen, Q.Y.; Chen, C.; Zeng, Z.; Cui, Y.P.; Xiao, J.C. Novel low-melting salts with donor–acceptor substituents as targets for second-order nonlinear optical applications. Chem. Commun., 2008, 13, 5016-5018.
[23]
Gravel, J.; Schmitzer, A.R. Transmembrane anion transport mediated by adamantyl-functionalized imidazolium salts. Supramol. Chem., 2014, 27, 364-371.
[24]
Li, S.; Yang, F.; Lv, T.; Lan, J.; Gao, G.; You, J. Synthesis of unsymmetrical imidazolium salts by direct quaternization of N-substituted imidazoles using arylboronic acids. Chem. Commun., 2014, 50, 3941-3943.
[25]
Gravel, J.; Schmitzer, A.R. Imidazolium and benzimidazolium-containing compounds: from simple toxic salts to highly bioactive drugs. Org. Biomol. Chem., 2017, 15, 1051-1071.
[26]
Sangeeta, G.P.V.; Murali Krishna Kumar, M.; Risy Namratha, J. PurnaNagasree, K. Computer Assisted Drug Repurposing: Anti TB activity in Non Antibiotics. Indian J. Chem. B., 2018, 57, 1295-1303.
[27]
Sarcina, M.; Mullineaux, C.W. Effects of tubulin assembly inhibitors on cell division in prokaryotes in vivo. FEMS Microbiol. Lett., 2000, 191, 25-29.
[28]
Trott, O.; Olson, A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem., 2010, 31, 455-461.
[29]
Sandeep, G.; Nagasree, K.P.; Hanisha, M.; Krishna Kumar, M.M. AUDocker LE: A GUI for virtual screening with AUTODOCK Vina. BMC Res. Notes, 2011, 4, 445-459.
[30]
Adelaine, K.W. Leung1, E.; Lucile White.; Larry Ross,J.;Robert, Reynolds,C.; Joseph, A.; DeVito.; David, Borhani, W. Structure of Mycobacterium tuberculosis FtsZ reveals unexpected, G protein-like conformational switches. J. Mol. Biol., 2004, 342, 953-970.
[31]
Rusinka-Roszak, D. Intramolecular O–H···O═C Hydrogen Bond Energy via the Molecular Tailoring Approach to RAHB Structures. J. Phys. Chem. A, 2015, 119, 3674-3687.
[32]
Ravelli, R.B.; Gigant, B.; Curmi, P.A.; Jourdain, I.; Lachkar, S.; Sobel, A.; Knossow, M. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature, 2004, 428, 198-202.
[33]
Buey, R.M.; Díaz, J.F. Andreu. The nucleotide switch of tubulin and microtubule assembly: A polymerization-driven structural change. J. Biol. Chem., 2006, 45, 5933-5938.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 1
Year: 2019
Page: [20 - 27]
Pages: 8
DOI: 10.2174/2211352516666180810101327

Article Metrics

PDF: 40
HTML: 3